InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Rosenberg Noah L., Directeur Médical. Insider active across 1 company, notably Travere Therapeutics, Inc.. Cumulatively, 6 filings have been logged. Breakdown: 0 buy · 4 sells. Total volume traded: €41k. Activity tracked since 11 May 2021. The latest transaction was disclosed on 13 August 2021 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
4,500 shares0Common StockSEC:0001209191-21-052083
4,500 shares0Common StockSEC:0001209191-21-052083:0
1,250 shares@ US$13.810.0004% mcap35.6% of flowCommon StockSEC:0001209191-21-048494:0
1,250 shares@ US$13.8135.6% of flowCommon StockSEC:0001209191-21-048494
375 shares@ US$19.1414.4% of flowCommon StockSEC:0001209191-21-032319
375 shares@ US$19.140.0001% mcap14.4% of flowCommon StockSEC:0001209191-21-032319:0
6 of 6 declarations
About Rosenberg Noah L.
Noah L. Rosenberg is the Chief Medical Officer at Travere Therapeutics, Inc. He is responsible for medical strategy and clinical research. His expertise in medicine and drug development is essential for guiding the company's research initiatives.
